Ovo Labs is a London-based biotech developing a series of therapeutics that act on different molecular mechanisms related to egg cell division. Its programs aim to increase IVF success and potentially improve infertility treatments. The company was co-founded by Professor Melina Schuh, Dr Agata Zielinska and Dr Oleksandr Yagensky. Ovo Labs announced £4M in funding on April 28, 2025. It intends to use the funds to expand operations and its R&D efforts.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

Apr 2025